scispace - formally typeset
C

Chunhua Yin

Researcher at Fudan University

Publications -  65
Citations -  5955

Chunhua Yin is an academic researcher from Fudan University. The author has contributed to research in topics: Drug carrier & Chitosan. The author has an hindex of 36, co-authored 61 publications receiving 5143 citations.

Papers
More filters
Journal ArticleDOI

Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles.

TL;DR: In vivo biodistribution suggested that NPs with slight negative charges and particle size of 150 nm were tended to accumulate in tumor more efficiently, and could serve as a guideline in the rational design of drug nanocarriers with maximized therapeutic efficacy and predictable in vivo properties.
Journal ArticleDOI

Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery.

TL;DR: Self-assembled nanoparticles between TMC-Cys and protein drugs could be an effective and safe oral delivery system and biocompatibility assessment revealed lack of toxicity of TMC -Cys NP.
Journal ArticleDOI

Superporous hydrogels containing poly(acrylic acid-co-acrylamide)/O-carboxymethyl chitosan interpenetrating polymer networks.

TL;DR: Due to the cross-linked O-CMC network, in vitro muco-adhesive force and mechanical properties, including compression and tensile modulus, of the SPH-IPN were greatly improved when compared with the CSPH.
Journal ArticleDOI

Size-dependent absorption mechanism of polymeric nanoparticles for oral delivery of protein drugs.

TL;DR: Rhodamine B labeled carboxylated chitosan grafted nanoparticles with different particle sizes and similar Zeta potentials provided guidelines for the rational design of oral nanocarriers for protein drugs in terms of particle size.
Journal ArticleDOI

Dual-targeting and pH/redox-responsive multi-layered nanocomplexes for smart co-delivery of doxorubicin and siRNA.

TL;DR: Multi-layered nanocomplexes were designed here to provide smart co-delivery of doxorubicin (DOX) and vascular endothelial growth factor (VEGF) siRNA and served as an effective and safe vector to maximize synergistic effect of chemodrugs and therapeutic genes.